Concomitant monitoring ofWT1andFLT3-ITDexpression inFLT3-ITDacute myeloid leukemia patients: which should we trust as a minimal residual disease marker?

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles